SCHEMBL8092637

SCHEMBL8092637

CNC(=O)Nc1ccc(-c2nc(N)cc(C3(S(=O)(=O)c4ccc(N)cc4)CC3)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.42
PIK3CA P42336 4/20 0.40
MTOR P42345 3/20 0.40
PIK3CG P48736 1/20 0.40
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA9 Q16790 2/20 0.39
PIP4K2A P48426 1/20 0.38
PIP4K2B P78356 1/20 0.38
PIK3CD O00329 7/20 0.37
PKM P14618 1/20 0.36
CYP2C19 P33261 1/20 0.36
SETD7 Q8WTS6 1/20 0.36
PRMT1 Q99873 1/20 0.36
KDM1A O60341 1/20 0.35
EPHX2 P34913 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8097257 0.93 ALDH1A1 (0.41) KMT2APIK3CAMTORPIK3CGCA12
SCHEMBL8083973 0.92 ALDH1A1 (0.43) KMT2APIK3CAMTORPIK3CGCA12
SCHEMBL8090246 0.92 PIK3CA (0.42) KMT2APIK3CAMTORPIK3CGPIP4K2A
SCHEMBL8099749 0.91 MTOR (0.40) KMT2APIK3CAMTORPIK3CGPIP4K2A
SCHEMBL8097712 0.89 KMT2A (0.39) KMT2APIK3CAMTORPIK3CGCA12
SCHEMBL8096342 0.89 PIK3CA (0.41) KMT2APIK3CAMTORPIK3CGPIP4K2A
SCHEMBL8089917 0.89 PIK3CA (0.39) KMT2APIK3CAMTORPIK3CGCA2
SCHEMBL8091073 0.88 KMT2A (0.37) KMT2APIK3CAMTORPIK3CGCA12
SCHEMBL8093151 0.88 KMT2A (0.37) KMT2APIK3CAMTORPIK3CGCA2
SCHEMBL8097448 0.87 PIK3CA (0.43) KMT2APIK3CAMTORPIK3CGPIP4K2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009007748-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES ASTRAZENECA AB (SE) 2009-01-15 WO disclosed